Top

Published in:

01-09-2009 | Review

Eosinophilic Esophagitis

Authors: Fouad J. Moawad, Ganesh R. Veerappan, Roy K. Wong

Published in: Digestive Diseases and Sciences | Issue 9/2009

Abstract

Eosinophilic esophagitis is a chronic inflammatory disorder characterized by dense eosinophilic infiltration of the esophageal mucosa. The pathogenesis is incompletely understood and food allergies and aeroallergens have been implicated. The most common clinical presentation in adults is dysphagia to solids. Its associated endoscopic findings are distinct and include concentric rings and longitudinal furrows, although endoscopy may be unremarkable in a minority of patients. A number of management strategies exist; however, data are limited in adults, and only a few are based on randomized controlled trials. Management options include dietary modifications, pharmacological therapy, and endoscopic dilation.

Katzka DA. Demographic data and symptoms of eosinophilic esophagitis in adults. Gastrointest Endosc Clin N Am. 2008;18:25–32. doi:10.1016/j.giec.2007.09.005.PubMedCrossRef

Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660–1669. doi:10.1053/j.gastro.2003.09.024.PubMedCrossRef

Croese J, Fairley SK, Masson JW, et al. Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc. 2003;58:516–522. doi:10.1067/S0016-5107(03)01870-4.PubMedCrossRef

Remedios M, Campbell C, Jones DM, Kerlin P. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63:3–12. doi:10.1016/j.gie.2005.07.049.PubMedCrossRef

Bonis PA. Putting the puzzle together: epidemiological and clinical clues in the etiology of eosinophilic esophagitis. Immunol Allergy Clin North Am. 2009;29:41–52. doi:10.1016/j.iac.2008.09.005.PubMedCrossRef

Chehade M, Sampson HA. Epidemiology and etiology of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:33–44. doi:10.1016/j.giec.2007.09.002.PubMedCrossRef

Pasha SF, DiBaise JK, Kim HJ, et al. Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case series and systematic review of the medical literature. Dis Esophagus. 2007;20:311–319. doi:10.1111/j.1442-2050.2007.00721.x.PubMedCrossRef

Straumann A. Clinical evaluation of the adult who has eosinophilic esophagitis. Immunol Allergy Clin North Am. 2009;29:11–18. doi:10.1016/j.iac.2008.09.007.PubMedCrossRef

Ronkainen J, Talley NJ, Aro P, et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based kalixanda study. Gut. 2007;56:615–620. doi:10.1136/gut.2006.107714.PubMedCrossRef

10.

Veerappan GR, Perry JL, Duncan TJ, et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol. 2009;7:420–426. doi:10.1016/jcgh.2008.10.009.PubMedCrossRef

11.

Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol. 2007;102:2627–2632. doi:10.1111/j.1572-0241.2007.01512.x.PubMedCrossRef

12.

Zink DA, Amin M, Gebara S, Desai TK. Familial dysphagia and eosinophilia. Gastrointest Endosc. 2007;65:330–334. doi:10.1016/j.gie.2006.07.021.PubMedCrossRef

13.

Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;351:940–941. doi:10.1056/NEJM200408263510924.PubMedCrossRef

14.

Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206. doi:10.1016/S1542-3565(05)00885-2.PubMedCrossRef

15.

Wolfsen HC, Hemminger LL, Achem SR. Eosinophilic esophagitis and Barrett’s esophagus with dysplasia. Clin Gastroenterol Hepatol. 2007;5:A18. doi:10.1016/j.cgh.2007.09.009.PubMedCrossRef

16.

Francalanci P, De Angelis P, Minnei F, et al. Eosinophilic esophagitis and Barrett’s esophagus: an occasional association or an overlap disease? Esophageal ‘double trouble’ in two children. Digestion. 2008;77:16–19. doi:10.1159/000114828.PubMedCrossRef

17.

Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102:1301–1306. doi:10.1111/j.1572-0241.2007.01179.x.PubMedCrossRef

18.

Spergel JM. Eosinophilic oesophagitis and pollen. Clin Exp Allergy. 2005;35:1421–1422. doi:10.1111/j.1365-2222.2005.02372.x.PubMedCrossRef

19.

Spergel JM, Brown-Whitehorn T. The use of patch testing in the diagnosis of food allergy. Curr Allergy Asthma Rep. 2005;5:86–90. doi:10.1007/s11882-005-0061-5.PubMedCrossRef

20.

Assa’ad A. Eosinophilic esophagitis: association with allergic disorders. Gastrointest Endosc Clin N Am. 2008;18:119–132. doi:10.1016/j.giec.2007.09.001.PubMedCrossRef

21.

Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363. doi:10.1053/j.gastro.2007.08.017.PubMedCrossRef

22.

Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83–90. doi:10.1172/JCI10224.PubMedCrossRef

23.

Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol. 2003;112:796–797. doi:10.1016/S0091-6749(03)01715-9.PubMedCrossRef

24.

Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol. 2007;41:451–453. doi:10.1097/01.mcg.0000248019.16139.67.PubMedCrossRef

25.

Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104:828–833. doi:10.1038/ajg.2008.169.PubMedCrossRef

26.

Moawad FJ, Veerappan GR, Duncan TJ, et al. The correlation between eosinophilic esophagitis and aeroallergens. Gastroenterology. 2009;136(Suppl 1):S1857. doi:10.1016/S0016-5085(09)61272-5.

27.

Onbasi K, Sin AZ, Doganavsargil B, Onder GF, Bor S, Sebik F. Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy. 2005;35:1423–1431. doi:10.1111/j.1365-2222.2005.02351.x.PubMedCrossRef

28.

Simon D, Marti H, Heer P, Simon HU, Braathen LR, Straumann A. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol. 2005;115:1090–1092. doi:10.1016/j.jaci.2005.01.017.PubMedCrossRef

29.

Blanchard C, Rothenberg ME. Basic pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:133–143. doi:10.1016/j.giec.2007.09.016.PubMedCrossRef

30.

Mishra A, Hogan SP, Brandt EB, Rothenberg ME. Il-5 promotes eosinophil trafficking to the esophagus. J Immunol. 2002;168:2464–2469.PubMed

31.

Wershil BK. Exploring the role of mast cells in eosinophilic esophagitis. Immunol Allergy Clin North Am. 2009;29:189–195. doi:10.1016/j.iac.2008.09.006.PubMedCrossRef

32.

Bullock JZ, Villanueva JM, Blanchard C, et al. Interplay of adaptive th2 immunity with eotaxin-3/c-c chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2007;45:22–31. doi:10.1097/MPG.0b013e318043c097.PubMedCrossRef

33.

Blanchard C, Wang N, Stringer KF, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536–547. doi:10.1172/JCI26679.PubMedCrossRef

34.

Furuta GT, Straumann A. Review article: the pathogenesis and management of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2006;24:173–182. doi:10.1111/j.1365-2036.2006.02984.x.PubMedCrossRef

35.

Rothenberg ME. Eosinophilia. N Engl J Med. 1998;338:1592–1600. doi:10.1056/NEJM199805283382206.PubMedCrossRef

36.

Mishra A. Mechanism of eosinophilic esophagitis. Immunol Allergy Clin North Am. 2009;29:29–40. doi:10.1016/j.iac.2008.09.010.PubMedCrossRef

37.

Chehade M. Translational research on the pathogenesis of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:145–156. doi:10.1016/j.giec.2007.09.013.PubMedCrossRef

38.

Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:435–442. doi:10.1111/j.1572-0241.2007.01594.x.PubMedCrossRef

39.

Bohm M, Richter JE. Treatment of eosinophilic esophagitis: overview, current limitations, and future direction. Am J Gastroenterol. 2008;103:2635–2644. Quiz 2645. doi:10.1111/j.1572-0241.2008.02116.x. PubMedCrossRef

40.

Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol. 2006;18:211–217. doi:10.1097/00042737-200602000-00015.PubMedCrossRef

41.

Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795–801. doi:10.1016/S0016-5107(05)00313-5.PubMedCrossRef

42.

Dellon ES, Aderoju A, Woosley JT, Sandler RS, Shaheen NJ. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol. 2007;102:2300–2313. doi:10.1111/j.1572-0241.2007.01396.x.PubMedCrossRef

43.

Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313–319. doi:10.1016/j.gie.2006.04.037.PubMedCrossRef

44.

Odze RD. Pathology of eosinophilic esophagitis: what the clinician needs to know. Am J Gastroenterol. 2009;104:485–490. doi:10.1038/ajg.2008.40.PubMedCrossRef

45.

Straumann A, Spichtin HP, Bucher KA, Heer P, Simon HU. Eosinophilic esophagitis: red on microscopy, white on endoscopy. Digestion. 2004;70:109–116. doi:10.1159/000080934.PubMedCrossRef

46.

Nurko S, Teitelbaum JE, Husain K, et al. Association of Schatzki ring with eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2004;38:436–441. doi:10.1097/00005176-200404000-00014.PubMedCrossRef

47.

Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol. 2002;109:363–368. doi:10.1067/mai.2002.121458.PubMedCrossRef

48.

Spergel JM, Brown-Whitehorn T, Beausoleil JL, Shuker M, Liacouras CA. Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol. 2007;119:509–511. doi:10.1016/j.jaci.2006.11.016.PubMedCrossRef

49.

Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109:1503–1512. doi:10.1016/0016-5085(95)90637-1.PubMedCrossRef

50.

Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98:777–782. doi:10.1111/j.1572-0241.2003.07390.x.PubMedCrossRef

51.

Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol. 2005;95:336–343.PubMedCrossRef

52.

Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4:1097–1102. doi:10.1016/j.cgh.2006.05.026.PubMedCrossRef

53.

Swoger JM, Weiler CR, Arora AS. Eosinophilic esophagitis: is it all allergies? Mayo Clin Proc. 2007;82:1541–1549. doi:10.4065/82.12.1541.PubMedCrossRef

54.

Faubion WA Jr, Perrault J, Burgart LJ, Zein NN, Clawson M, Freese DK. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998;27:90–93. doi:10.1097/00005176-199807000-00016.PubMedCrossRef

55.

Teitelbaum JE, Fox VL, Twarog FJ, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology. 2002;122:1216–1225. doi:10.1053/gast.2002.32998.PubMedCrossRef

56.

Arora AS, Perrault J, Smyrk TC. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc. 2003;78:830–835. doi:10.4065/78.7.830.PubMedCrossRef

57.

Helou EF, Simonson J, Arora AS. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol. 2008;103:2194–2199. doi:10.1111/j.1572-0241.2008.01989.x.PubMedCrossRef

58.

Noel RJ, Putnam PE, Collins MH, et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568–575. doi:10.1016/S1542-3565(04)00240-X.PubMedCrossRef

59.

Aceves SS, Bastian JF, Newbury RO, Dohil R. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol. 2007;102:2271–2279. Quiz 2280. doi:10.1111/j.1572-0241.2007.01379.x. PubMedCrossRef

60.

Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006;131:1381–1391. doi:10.1053/j.gastro.2006.08.033.PubMedCrossRef

61.

Liacouras CA, Wenner WJ, Brown K, Ruchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr. 1998;26:380–385. doi:10.1097/00005176-199804000-00004.PubMedCrossRef

62.

Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol. 2008;6:165–173. doi:10.1016/j.cgh.2007.11.008.PubMedCrossRef

63.

Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic oesophagitis: a novel treatment using montelukast. Gut. 2003;52:181–185. doi:10.1136/gut.52.2.181.PubMedCrossRef

64.

Vanderhoof JA, Young RJ. Allergic disorders of the gastrointestinal tract. Curr Opin Clin Nutr Metab Care. 2001;4:553–556. doi:10.1097/00075197-200111000-00016.PubMedCrossRef

65.

Garrett JK, Jameson SC, Thomson B, et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol. 2004;113:115–119. doi:10.1016/j.jaci.2003.10.049.PubMedCrossRef

66.

Stein ML, Collins MH, Villanueva JM, et al. Anti-il-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol. 2006;118:1312–1319. doi:10.1016/j.jaci.2006.09.007.PubMedCrossRef

67.

Foroughi S, Foster B, Kim N, et al. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J Allergy Clin Immunol. 2007;120:594–601. doi:10.1016/j.jaci.2007.06.015.PubMedCrossRef

68.

Straumann A, Bussmann C, Conus S. Infliximab, a monoclonal antibody to TNF-a, for severe eosinophilic esophagitis in adults: a prospective, translational pilot-study. Gastroenterology. 2008;134(Supp1):A-105.CrossRef

69.

Ngo P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus–peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101:1666–1670. doi:10.1111/j.1572-0241.2006.00562.x.PubMedCrossRef

70.

Dranove JE, Horn DS, Davis MA, Kernek KM, Gupta SK. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr. 2009;154:96–100. doi:10.1016/j.jpeds.2008.07.042.PubMedCrossRef

71.

Pasha SF, Sharma VK, Crowell MD. Current concepts and treatment options in eosinophilic esophagitis. Curr Opin Investig Drugs. 2006;7:992–996.PubMed

72.

Cantu P, Velio P, Prada A, Penagini R. Ringed oesophagus and idiopathic eosinophilic oesophagitis in adults: an association in two cases. Dig Liver Dis. 2005;37:129–134. doi:10.1016/j.dld.2004.04.008.PubMedCrossRef

73.

Zimmerman SL, Levine MS, Rubesin SE, et al. Idiopathic eosinophilic esophagitis in adults: the ringed esophagus. Radiology. 2005;236:159–165. doi:10.1148/radiol.2361041100.PubMedCrossRef

74.

Vasilopoulos S, Murphy P, Auerbach A, et al. The small-caliber esophagus: an unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis. Gastrointest Endosc. 2002;55:99–106. doi:10.1067/mge.2002.118645.PubMedCrossRef

75.

Schoepfer AM, Gschossmann J, Scheurer U, Seibold F, Straumann A. Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids. Endoscopy. 2008;40:161–164. doi:10.1055/s-2007-995345.PubMedCrossRef

76.

Potter JW, Saeian K, Staff D, et al. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc. 2004;59:355–361. doi:10.1016/S0016-5107(03)02713-5.PubMedCrossRef

77.

Morrow JB, Vargo JJ, Goldblum JR, Richter JE. The ringed esophagus: histological features of GERD. Am J Gastroenterol. 2001;96:984–989. doi:10.1111/j.1572-0241.2001.03682.x.PubMedCrossRef

78.

Cohen MS, Kaufman AB, Palazzo JP, Nevin D, Dimarino AJ Jr, Cohen S. An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2007;5:1149–1153. doi:10.1016/j.cgh.2007.05.017.PubMedCrossRef

Title: Eosinophilic Esophagitis
Authors: Fouad J. Moawad
Ganesh R. Veerappan
Roy K. Wong
Publication date: 01-09-2009
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 9/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-009-0873-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2009

Advantages and Pitfalls of the Polymerase Chain Reaction in the Diagnosis of Esophageal Ulcers in AIDS Patients

Expression of p53, VEGF, Microvessel Density, and Cyclin-D1 in Noncancerous Tissue of Inflammatory Bowel Disease

Steatocholecystitis and Fatty Gallbladder Disease

A Comparison of Magnifying Chromoendoscopy Versus Histopathology of Forceps Biopsy Specimen in the Diagnosis of Minute Flat Adenoma of the Colon

Chronic Mucosal Inflammation of the Gastric Cardia in Gastroesophageal Reflux Disease Is Not Regulated by FOXP3-Expressing T cells

Esophageal Motility in Nonacid Reflux Compared with Acid Reflux

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage